Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Confocal.nl is a Netherlands-based technology company that develops and commercializes high-resolution fluorescence microscopy solutions for the life sciences market. Founded in 2016 as a spin-off from the University of Amsterdam, the company's core technology is the Re-scan Confocal Microscope (RCM), which significantly improves lateral resolution and sensitivity compared to traditional confocal systems. Their modular RCM units are designed to upgrade standard widefield fluorescence microscopes into super-resolution systems, providing researchers with a cost-effective path to high-performance imaging. The company serves academic and industrial laboratories worldwide, focusing on applications in cell biology, neuroscience, and drug discovery research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Confocal.nl.